To determine the efficacy of a 12-week supervised, hypertrophy-oriented strength training program in preserving skeletal muscle mass, physical function, and quality of life in patients with unresectable pancreatic cancer compared to standard care.
Diagnosis of locally advanced or metastatic unresectable pancreatic cancer
Undergoing chemotherapy or immunotherapy treatment
Age ≥ 18 years
ECOG score ≤ 2
Any relative or absolute contraindication that prevents the performance of training or physical tests.
Diagnosis of other types of primary cancer
Inability to understand Spanish for proper comprehension of the informed consent and questionnaires